C vs CDTX
Citigroup Inc. (C) versus Cidara Therapeutics Inc (CDTX) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
C currently screens at market cap $214.73B and trailing P/E 15.5. CDTX currently screens at market cap $6.96B.
Not investment advice. Open the C and CDTX stock pages for the full models.
Not investment advice.